Biotechnological Ricin for Immunological Studies from Germany
Recombinant ricin toxin produced through biotech processes for studying immune responses and antibody production. Classified in HTS 3002.49.0010 as a modified toxin for diagnostic and therapeutic research. Used in labs to develop countermeasures against bioterrorism agents.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include biotech origin certificate and sequence data to justify classification under modified immunological products
• Use IATA-compliant packaging for air import; verify receiver's BSL-3 lab status to prevent denial